TrialThe oncologist2021

Phase II Study of 5-Fluorouracil, Oxaliplatin plus Dasatinib (FOLFOX-D) in First-Line Metastatic Pancreatic Adenocarcinoma.

Thomas J George et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.